Patent ID: 9439896
Filing Date: 2016-09-13
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A compound selected from the group consisting of a compound of formula (I): a tautomeric form and stereochemically isomeric form thereof, wherein W is —N(R each R Y represents -E-D; D represents a 3, 4, 5, 6, 7 or 8 membered monocyclic carbocyclyl or a 3, 4, 5, 6, 7 or 8 membered monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S, wherein said carbocyclyl and heterocyclyl may each be optionally substituted by one or more R E represents a bond; R R R R wherein ring A is a monocyclic 5 to 7 membered saturated heterocycle containing one heteroatom selected from N, O and S, said heteroatom not being positioned in alpha position of the double bond, wherein ring A is optionally being substituted with cyano, C 1-4 alkyl, hydroxyC 1-4 alkyl, H 2 N—C 1-4 alkyl, (C 1-4 alkyl)NH—C 1-4 alkyl, (C 1-4 alkyl) 2 N—C 1-4 alkyl, haloC 1-4 alkyl) NH—C 1-4 alkyl, C 1-4 alkoxyC 1-4 alkyl, —C(═O)—NH 2 , —C(═O)—NH(C 1-4 alkyl), —C(═O)—N(C 1-4 alkyl) 2 ; R R R R R R R R R R R n independently represents an integer equal to 0, 1, 2, 3 or 4; or an N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof.